Liver-specific deletion of Sirt1 results in hepatic steatosis and inflammation in mice [6], while treatment with Sirt1 activators or Sirt1 overexpression ameliorates fatty liver and reduces lipogenic gene expression [5, 7]. This evidence concerns the gene SIRT1 and Hepatic steatosis.